Logo image of AKE.PA

ARKEMA (AKE.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:AKE - FR0010313833 - Common Stock

50.8 EUR
-2.75 (-5.14%)
Last: 1/16/2026, 5:29:48 PM
Fundamental Rating

4

AKE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 69 industry peers in the Chemicals industry. AKE has only an average score on both its financial health and profitability. AKE is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year AKE was profitable.
  • AKE had a positive operating cash flow in the past year.
  • AKE had positive earnings in each of the past 5 years.
  • AKE had a positive operating cash flow in each of the past 5 years.
AKE.PA Yearly Net Income VS EBIT VS OCF VS FCFAKE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

  • With a Return On Assets value of 0.89%, AKE perfoms like the industry average, outperforming 52.17% of the companies in the same industry.
  • The Return On Equity of AKE (1.76%) is comparable to the rest of the industry.
  • The Return On Invested Capital of AKE (2.77%) is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for AKE is in line with the industry average of 6.95%.
Industry RankSector Rank
ROA 0.89%
ROE 1.76%
ROIC 2.77%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
AKE.PA Yearly ROA, ROE, ROICAKE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • AKE has a Profit Margin (1.38%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of AKE has declined.
  • With a Operating Margin value of 5.40%, AKE perfoms like the industry average, outperforming 57.97% of the companies in the same industry.
  • In the last couple of years the Operating Margin of AKE has declined.
  • AKE has a worse Gross Margin (18.68%) than 75.36% of its industry peers.
  • AKE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.4%
PM (TTM) 1.38%
GM 18.68%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
AKE.PA Yearly Profit, Operating, Gross MarginsAKE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

5

2. Health

2.1 Basic Checks

  • AKE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • AKE has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for AKE has been reduced compared to 5 years ago.
  • The debt/assets ratio for AKE is higher compared to a year ago.
AKE.PA Yearly Shares OutstandingAKE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AKE.PA Yearly Total Debt VS Total AssetsAKE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • AKE has an Altman-Z score of 1.82. This is not the best score and indicates that AKE is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 1.82, AKE is not doing good in the industry: 69.57% of the companies in the same industry are doing better.
  • AKE has a debt to FCF ratio of 17.51. This is a negative value and a sign of low solvency as AKE would need 17.51 years to pay back of all of its debts.
  • The Debt to FCF ratio of AKE (17.51) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.57 indicates that AKE is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.57, AKE is in line with its industry, outperforming 44.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 17.51
Altman-Z 1.82
ROIC/WACC0.56
WACC4.93%
AKE.PA Yearly LT Debt VS Equity VS FCFAKE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 3.07 indicates that AKE has no problem at all paying its short term obligations.
  • AKE has a better Current ratio (3.07) than 85.51% of its industry peers.
  • A Quick Ratio of 2.26 indicates that AKE has no problem at all paying its short term obligations.
  • The Quick ratio of AKE (2.26) is better than 89.86% of its industry peers.
Industry RankSector Rank
Current Ratio 3.07
Quick Ratio 2.26
AKE.PA Yearly Current Assets VS Current LiabilitesAKE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2

3. Growth

3.1 Past

  • The earnings per share for AKE have decreased strongly by -38.40% in the last year.
  • AKE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.10% yearly.
  • AKE shows a decrease in Revenue. In the last year, the revenue decreased by -2.71%.
  • AKE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.78% yearly.
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
Revenue 1Y (TTM)-2.71%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%

3.2 Future

  • The Earnings Per Share is expected to decrease by -2.41% on average over the next years.
  • Based on estimates for the next years, AKE will show a small growth in Revenue. The Revenue will grow by 1.07% on average per year.
EPS Next Y-42.01%
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
EPS Next 5Y-2.41%
Revenue Next Year-5.26%
Revenue Next 2Y-2.07%
Revenue Next 3Y-0.23%
Revenue Next 5Y1.07%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AKE.PA Yearly Revenue VS EstimatesAKE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
AKE.PA Yearly EPS VS EstimatesAKE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

7

4. Valuation

4.1 Price/Earnings Ratio

  • AKE is valuated reasonably with a Price/Earnings ratio of 9.86.
  • Based on the Price/Earnings ratio, AKE is valued cheaply inside the industry as 91.30% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.54, AKE is valued rather cheaply.
  • AKE is valuated reasonably with a Price/Forward Earnings ratio of 9.47.
  • Based on the Price/Forward Earnings ratio, AKE is valued cheaply inside the industry as 92.75% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.31, AKE is valued rather cheaply.
Industry RankSector Rank
PE 9.86
Fwd PE 9.47
AKE.PA Price Earnings VS Forward Price EarningsAKE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • AKE's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AKE is cheaper than 81.16% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, AKE is valued cheaper than 82.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.9
EV/EBITDA 6.25
AKE.PA Per share dataAKE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • A cheap valuation may be justified as AKE's earnings are expected to decrease with -8.39% in the coming years.
PEG (NY)N/A
PEG (5Y)100.93
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 6.89%, AKE is a good candidate for dividend investing.
  • AKE's Dividend Yield is rather good when compared to the industry average which is at 2.45. AKE pays more dividend than 94.20% of the companies in the same industry.
  • AKE's Dividend Yield is rather good when compared to the S&P500 average which is at 1.92.
Industry RankSector Rank
Dividend Yield 6.89%

5.2 History

  • On average, the dividend of AKE grows each year by 6.86%, which is quite nice.
Dividend Growth(5Y)6.86%
Div Incr Years4
Div Non Decr Years4
AKE.PA Yearly Dividends per shareAKE.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • AKE pays out 214.17% of its income as dividend. This is not a sustainable payout ratio.
  • The Dividend Rate of AKE has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP214.17%
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
AKE.PA Yearly Income VS Free CF VS DividendAKE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
AKE.PA Dividend Payout.AKE.PA Dividend Payout, showing the Payout Ratio.AKE.PA Dividend Payout.PayoutRetained Earnings

ARKEMA

EPA:AKE (1/16/2026, 5:29:48 PM)

50.8

-2.75 (-5.14%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-07
Earnings (Next)02-25
Inst Owners59.92%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap3.86B
Revenue(TTM)9.24B
Net Income(TTM)127.00M
Analysts71.43
Price Target63.94 (25.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.89%
Yearly Dividend3.47
Dividend Growth(5Y)6.86%
DP214.17%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.47%
Min EPS beat(2)-10.34%
Max EPS beat(2)-6.61%
EPS beat(4)0
Avg EPS beat(4)-11.01%
Min EPS beat(4)-18.44%
Max EPS beat(4)-6.61%
EPS beat(8)2
Avg EPS beat(8)-6.6%
EPS beat(12)6
Avg EPS beat(12)-0.72%
EPS beat(16)10
Avg EPS beat(16)8.4%
Revenue beat(2)0
Avg Revenue beat(2)-0.82%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)-0.46%
Revenue beat(4)0
Avg Revenue beat(4)-0.78%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)-0.46%
Revenue beat(8)2
Avg Revenue beat(8)-0.58%
Revenue beat(12)3
Avg Revenue beat(12)-1.09%
Revenue beat(16)7
Avg Revenue beat(16)0.41%
PT rev (1m)-1.57%
PT rev (3m)-17.66%
EPS NQ rev (1m)-15.28%
EPS NQ rev (3m)-21.44%
EPS NY rev (1m)-1.47%
EPS NY rev (3m)-15.94%
Revenue NQ rev (1m)-0.48%
Revenue NQ rev (3m)-4.64%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-1.55%
Valuation
Industry RankSector Rank
PE 9.86
Fwd PE 9.47
P/S 0.42
P/FCF 15.9
P/OCF 3.94
P/B 0.54
P/tB 1.76
EV/EBITDA 6.25
EPS(TTM)5.15
EY10.14%
EPS(NY)5.36
Fwd EY10.56%
FCF(TTM)3.19
FCFY6.29%
OCF(TTM)12.88
OCFY25.36%
SpS121.43
BVpS94.94
TBVpS28.82
PEG (NY)N/A
PEG (5Y)100.93
Graham Number104.89
Profitability
Industry RankSector Rank
ROA 0.89%
ROE 1.76%
ROCE 3.93%
ROIC 2.77%
ROICexc 2.78%
ROICexgc 4.6%
OM 5.4%
PM (TTM) 1.38%
GM 18.68%
FCFM 2.63%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexgc growth 3Y-19.33%
ROICexgc growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score4
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 17.51
Debt/EBITDA 3.1
Cap/Depr 89.12%
Cap/Sales 7.98%
Interest Coverage 20.79
Cash Conversion 73.91%
Profit Quality 191.34%
Current Ratio 3.07
Quick Ratio 2.26
Altman-Z 1.82
F-Score4
WACC4.93%
ROIC/WACC0.56
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
EPS Next Y-42.01%
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
EPS Next 5Y-2.41%
Revenue 1Y (TTM)-2.71%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%
Revenue Next Year-5.26%
Revenue Next 2Y-2.07%
Revenue Next 3Y-0.23%
Revenue Next 5Y1.07%
EBIT growth 1Y-33.91%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year42.37%
EBIT Next 3Y16.8%
EBIT Next 5Y12.01%
FCF growth 1Y-53.98%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-22.65%
OCF growth 3Y7%
OCF growth 5Y-2.92%

ARKEMA / AKE.PA FAQ

What is the fundamental rating for AKE stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKE.PA.


Can you provide the valuation status for ARKEMA?

ChartMill assigns a valuation rating of 7 / 10 to ARKEMA (AKE.PA). This can be considered as Undervalued.


How profitable is ARKEMA (AKE.PA) stock?

ARKEMA (AKE.PA) has a profitability rating of 4 / 10.


Can you provide the financial health for AKE stock?

The financial health rating of ARKEMA (AKE.PA) is 5 / 10.


Is the dividend of ARKEMA sustainable?

The dividend rating of ARKEMA (AKE.PA) is 6 / 10 and the dividend payout ratio is 214.17%.